• |
  • |
  • |
  • |
Donate

Product

Interim results of phase 2A study of VX-770 to evaluate safety, pharmacokinetics, and biomarkers of CFTR activity in CF subjects with G551D

Center:
Fiscal Year:
2009
Contact Information:
Product Description:
Keyword(s):
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A